Clarify Health

DECEMBER 15, 2023

Beyond Theory: Harnessing Incentives to Drive Value-Based Care Initiatives Healthcare Unbound episode recap: On this episode of the Healthcare Unbound podcast , behavioral economics expert Dr. Zeke Emanuel discusses how to create physician incentives to control costs and improve outcomes in healthcare. Emanuel says.

Physicians 52

Physicians Doctors Healthcare Healthcare 52

PM360

JULY 21, 2022

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks. THE CHALLENGE.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

MedCity News

NOVEMBER 23, 2022

Among the takeaways from HLTH 2022 were the impact of consolidation on clinicians, behavioral health tools to help consumers manage stress and anxiety more productively, and how health tech and medtech companies are supporting remote patient monitoring and testing.

Management 106

Management Patients Physicians 106

Nixon Gwilt Law

JANUARY 25, 2022

This webinar is geared toward those wanting to leverage the new RTM codes or learn more about expanded CCM and PCM reimbursement opportunities in the 2022 MPFS. If you missed our most anticipated webinar of the year, be sure to catch the replay below! Scroll to the bottom to download your CPT code chart.). We've got you covered!

Management 52

Management Physicians FDA Patients 52

PM360

NOVEMBER 21, 2022

Doctor Docs: Physicians Need Info to Treat Long COVID. In a Sermo survey of more than 1,100 global physicians, 86% felt there is a lack of clinical guidance on how to diagnose Long COVID and 87% felt there is a lack of clinical guidance on how to treat Long COVID in patients. following a COVID infection.

Healthcare 52

Healthcare Healthcare Doctors Physicians 52

Nixon Gwilt Law

JULY 20, 2023

Now, in the first proposed Medicare Physician Fee Schedule (“MPFS”) since the PHE ended, CMS is clearing up some lingering unanswered questions, with a particular focus on flexibilities established in the 2023 Consolidated Appropriations Act (“2023 CAA”). The 2023 CAA further extended these flexibilities through the end of 2024.

Physicians 52

Physicians Patients Consulting Management 52

pharmaphorum

JULY 7, 2022

Recent progress in immunotherapy, targeted therapies, and genetic testing has allowed physicians to treat breast cancer more precisely, says Daiichi Sankyo’s Markus Kosch. ASCO 2022: Checkpoint inhibitors, Enhertu in spotlight. The post Deep Dive: Oncology 2022 appeared first on. New horizons in breast cancer care.

Healthcare Provider 52

Healthcare Provider Physicians Healthcare Healthcare 52

World of DTC Marketing

AUGUST 30, 2022

billion in 2022. Display is an incredibly low-effort way to spend your marketing budget, whether trying to reach physicians or patients. While some have seen luck with ePocrates, it’s been my experience that physicians don’t like ads when looking up medical information for patients.

Physicians 270

Physicians Marketing Pharma Insurance 270

Nixon Gwilt Law

JULY 26, 2022

The much-anticipated 2023 Medicare Physician Fee Schedule Proposed Rule is here, and we covered everything you need to know in a one-hour webinar! You can submit feedback on next year's proposed reimbursement until early September 2022 (60 days after the Proposed Rule posts in the Federal Register). How to Influence the Final Rule.

Physicians 52

Physicians Healthcare Provider Management Healthcare 52

Nixon Gwilt Law

JULY 11, 2022

Every summer when the Centers for Medicare and Medicaid Services (“CMS”) releases the Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”), the Nixon Gwilt Law (“NGL”) team excitedly opens the two-thousand-something-page PDF and immediately keys “ctrl+F” (or command+F for us Mac users) to jump to our most anticipated section(s).

Physicians 52

Physicians Management Healthcare Provider Patients 52

Legacy MEDSearch

DECEMBER 7, 2022

The company hit an important milestone in March 2022 when it received U.S. This was followed in September 2022 by another important step as the first surgery using the system was performed by orthopedic surgeon Laith M. Food and Drug Administration market clearance for the ArthroFree System. Lazurite is located in Cleveland, OH (est.

Networking 98

Networking Medical Food and Drug Administration Recruitment 98

pharmaphorum

SEPTEMBER 22, 2022

What physicians need from post-pandemic pharma comms. Frontiers Health 2022. Read Deep Dive: Communications & Commercialisation 2022 in full. The post Deep Dive: Communications & Commercialisation 2022 appeared first on. Moving forward the evolution of digital maturity in pharma.

Pharma 52

Pharma Marketing Physicians Pharmaceutical 52

PM360

SEPTEMBER 15, 2022

based physicians reveals that a majority are concerned and confused about what constitutes a life-threatening emergency that would make an abortion procedure legal in those 11 states where it has been banned. Doctor Docs: Doctors Left Concerned After Roe v. Wade Overturn. A recent Sermo study of 240 U.S.-based Or must it be 100%?”.

Healthcare 52

Healthcare Healthcare Doctors Physicians 52

Nixon Gwilt Law

AUGUST 2, 2022

CMS will delay the requirement for an in-person visit with the physician/practitioner (and FQHCs/RHCs) within 6 months prior to an initial mental health telehealth service, and again at subsequent intervals for purposes of diagnosis/evaluation/treatment of a mental health disorder.

Physicians 52

Physicians Training Education Patients 52

MedCity News

OCTOBER 18, 2022

According to the motion, more than one third of Planned Parenthood South Atlantic’s abortion patients between July 1 and September 30, 2022 came from out of state, totalling 1,317 people. In the same time period last year, just 322 patients came from out of state for abortions.

Physicians 96

Physicians Medical Patients Biopharma 96

Eversana Intouch

JANUARY 11, 2022

Welcome to 2022! Nurse practitioners (NPs) and physician assistants (PAs) have always been prescribers, but as doctors shift out of their practices, NPs and PAs are an audience that shouldn’t be an afterthought. And physicians agree, according to new data from IQVIA.) “It We will all continue this game of musical chairs in 2022.

Marketing 52

Marketing Pharma Medical science Media 52

PM360

AUGUST 29, 2022

Over-the-Counter (OTC) and Prescription (Rx) brands have invested over $3 billion in linear TV advertising during the first half of 2022, with no signs of letting up. P&G’s Nervive had the highest performing OTC creative in the first half of 2022 after the brand’s launch just last year. Impressions. 320 million. Brand / Creative.

Pharma 98

Pharma Prescription Marketing Pharmaceutical Sales 98

PM360

OCTOBER 24, 2022

The efforts of GoodRx to support and value their employees is demonstrated by the five employer awards won in 2022 and 12 awards in 2021, and the Best Leadership Teams, Best Marketing Team, Best Engineering Team, and Best Places to Work In Los Angeles awards in 2022. Social Responsibility.

Insurance 40

Insurance Prescription Healthcare Healthcare 40

PM360

JULY 26, 2023

is facing an aging population, a mounting physician shortage, and increasing demands for a more equitable healthcare system. 2 It’s no wonder physicians across the country are limiting time with the industry and prioritizing their limited time with their patients. Today, the U.S. 1 According to the U.S.

Healthcare 98

Healthcare Healthcare Physicians Doctors 98

PM360

APRIL 22, 2024

In fact, according to a 2022 survey, most HCPs (~63%) prefer to hear directly from experts, KOLs, or peers regarding information about the latest in research, trials, and treatments. Over 70% of physicians express a desire for information on clinical trials, treatments, and procedures to reflect the demographics of their patients.

Physicians 52

Physicians Education Healthcare Healthcare 52

Clarify Health

NOVEMBER 30, 2023

A leading not-for-profit health organization on the East Coast was looking to unlock new growth strategies and better insights into physician behaviors and trends. The health organization realized it needed a new analytics partner that could precisely pinpoint opportunities to grow in-network referrals and improve physician alignment.

Physicians 52

Physicians Networking Leads Patients 52

MedCity News

SEPTEMBER 9, 2022

Panelists at a session on diagnostics at MedtechVision 2022, a hybrid conference organized by MedtechWomen stressed that consumer and physician experience with a product is what is key in medtech innovation compared with simply adding bells and whistles.

Physicians 97

Physicians Patients 97

Pharmaceutical Technology

SEPTEMBER 13, 2022

With success in the metastatic setting, pharma companies, researchers and physicians have invested heavily in exploring the use of immune checkpoint inhibitors (ICIs) for the treatment of locally advanced disease, hoping to increase response rates and prevent disease progression. appeared first on Pharmaceutical Technology.

Patients 69

Patients Physicians Safety Pharma 69

World of DTC Marketing

MARCH 2, 2022

medical professionals, analyzed the adoption of telemedicine across its physician user base from January 2020 through June 2021 and conducted a study of patients’ experiences with telemedicine during the same time frame. Still, telehealth will NOT replace a visit to a physician’s office for more serious issues.

Physicians 154

Physicians Doctors Patients Training 154

MedCity News

JULY 1, 2022

Nearly half of health systems and physician groups in the U.S. are behind on their 2022 revenue goals, and healthcare executives are worried about increasing costs, shrinking margins and the impending recession, according to a new report.

Physicians 98

Physicians Healthcare Healthcare Leads 98

Clarivate

OCTOBER 10, 2022

Clarivate oncology experts share key takeaways from the 2022 ESMO Congress and their expected impact on the drug treatment landscape and patients. Read on to for insights from our analysts on: Global highlights from ESMO 2022. Key ESMO 2022 highlights from Mainland China. Seven global highlights from ESMO 2022.

Marketing 52

Marketing Safety Patients Competition 52

PM360

AUGUST 9, 2022

Sermo , a physician-first online community, found the tracks at ASCO that oncologists felt were the most transformative to be breast cancer (58%), lung cancer (34%), and developmental therapeutics—molecularly targeted agents and tumor biology (32%).

Healthcare 52

Healthcare Healthcare Food and Drug Administration FDA 52

pharmaphorum

DECEMBER 16, 2022

Capitainer, a Swedish med-tech focused on self-sampling solutions, has tapped entrepreneur and physician Dr Martin Carlsson to join its Advisory Board. The post Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022 appeared first on. Check out our other roundups for pharma and agency hires.

Pharma 52

Pharma Healthcare Healthcare Management 52

Nixon Gwilt Law

NOVEMBER 16, 2021

If you are in the digital health industry, particularly the remote patient monitoring (“RPM”) space, you have likely heard of the remote therapeutic monitoring (“RTM”) codes finalized in the 2022 Medicare Physician Fee Schedule Final Rule (the “Final Rule”). blood pressure monitors and pulse oximeters) as a new service line?

Physicians 52

Physicians FDA Medical Manufacturing 52

European Pharmaceutical Review

JANUARY 24, 2023

The three new European hires are: Maria Lehretz, Medical Director, Velocity Leipzig, Germany Maria has nearly a decade of experience as a clinical research physician, and has worked on approximately 70 clinical trials. Velocity acquired four clinical research sites in Europe from July 2022 onwards across the UK and Germany.

Key account management 96

Key account management Physicians Networking Management 96

Nixon Gwilt Law

JANUARY 6, 2022

If you are interested in leveraging the new RTM codes or learning more about expanded CCM and PCM reimbursement opportunities in the 2022 MPFS, join Carrie Nixon, Kaitlyn O’Connor, and Reema Taneja on January 19, 2022 at Noon ET! We're back with our most-anticipated webinar of the year! Register Here.

Management 52

Management Physicians Patients 52

Clarivate

JULY 5, 2023

The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. In 2022, it made its manufacturer, AbbVie, $21.2bn. According to 2022 primary market research from Clarivate, 62% of payers indicated that they cover Humira on ‘preferred brand’ status, while 16% of payers cover Humira on specialty tier.

Marketing 97

Marketing Physicians Manufacturing Competition 97

PM360

AUGUST 9, 2022

2 and over a million actively licensed physicians 3 are available to prescribe them? For Nurtec , a migraine medication, the numbers are even more skewed—only 14% of prescribers accounted for 80% of prescriptions between March 2020 and February 2022. Symphony Health Solutions, practitioner insight’s data, 2022. References: 1.

Prescription 52

Prescription Doctors Specialization Physicians 52

pharmaphorum

NOVEMBER 3, 2022

At Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock sat down with Matthew Holt, the founder and publisher of the Health Care Blog and a long-time self-described “digital health curmudgeon”. They also talk about the age-old question of whether and how much AI can replace human physicians and therapists, now and in the future.

Physicians 52

Physicians Patients 52

Medical Device Success

FEBRUARY 25, 2022

At the same time, don’t miss out on the 2022 podcasts where we are diving into Value Based Care and Artificial Intelligence. Episode 55 Driving Sales with Physician Micro-Marketing in MedTech – My guest is Scott Alexander, CEO, Jairus Physician Micromarketing. And, we are rated #2 of Medical Device Podcasts by Feedspot.com.

Medical 130

Medical Recruitment Doctors Physicians 130

PM360

JUNE 26, 2023

As the NIH states, sourcing feedback from just one demographic group can create a gap in fundamental understanding of diseases and responses to treatments, impacting clinical decisions, guidance that physicians offer to patients, and new treatment development.

Recruitment 98

Recruitment Physicians Marketing Transportation 98

European Pharmaceutical Review

JUNE 28, 2022

NEDA-3 is an important endpoint for physicians to consider when deciding to initiate high efficacy therapy, with this latest data from Alithios we can clearly see the benefit of starting Kesimpta early versus switching to it later from teriflunomide.”. The data were presented at the 2022 European Academy of Neurology (EAN) Annual Meeting.

Patients 84

Patients Physicians Pharmaceutical 84